New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day
Standards-first agent delivers faster and more consistent EDC and DQS builds PLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly...
Covered in this story
What has happened since
- Veeva Systems is up 16.2% since this was published, 26 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Veeva Systems
- Wells Fargo: $265 → $330 by Sep 2027 · Overweight via Investing.com
- Piper Sandler: $282 → $320 by Aug 2027 · Overweight via Investing.com
- Stifel: $282 → $300 by Aug 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $VEEV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Veeva Systems →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.